← American Pharmacists Association (APhA)
CMSRulemakingCMS-2016-0148

Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2018 (CMS-9934-P)

RIN
—
Last modified
Sep 23, 2020
Comment window
closed 3582d ago
American Pharmacists Association (APhA) filings
1

Activity

American Pharmacists Association (APhA) filed 1 comment on this docket between Oct 11, 2016 and Oct 11, 2016. 71 other organizations filed here. The comment window closed 3582d ago.

What American Pharmacists Association (APhA) filed (1)

Oct 11, 2016· DC --American Pharmacists Association (APhA)· CMS-2016-0148-0566

The American Pharmacists Association (APhA) is pleased to submit these comments regarding the Centers for Medicare & Medicaid Services (CMS's) proposed rule on benefit and payment parameters for the exchange plans for 2018 (the "Proposed Rule"). Founded in 1852 as the American Pharmaceutical Association, APhA represents more than 62,000 pharmacists, pharmaceutical scientists, student pharmacists, pharmacy technicians, and others interested in improving medication use and advancing patient care. APhA members provide care in all practice settings, including community pharmacies, hospitals, long-term care facilities, physicians' offices, community health centers, managed care organizations, hospice settings, and the uniformed services. We thank CMS for the opportunity to comment on the Proposed Rule. APhA was pleased to see CMS continue its efforts to improve patients' access to necessary medications as well as recommend the use of prescription drug utilization data to help improve the predictive ability of the public health insurance exchanges' risk-adjustment program to more accurately reflect enrollees' health care costs (see, attached comment letter). Thank you for the opportunity to provide feedback on the Proposed Rule and for your consideration of our comments. If you have any questions or require additional information, please contact, Michael Baxter, Director of Regulatory Affairs, at mbaxter@aphanet.org or by phone at (202) 429-7538. Sincerely, Thomas E. Menighan, BSPharm, MBA, ScD (Hon), FAPhA Executive Vice President and CEO cc:Stacie S. Maass, RPh, JD, Senior Vice President, Pharmacy Practice and Government Affairs

View on regulations.gov →

Abstract

This proposed rule sets forth payment parameters and provisions related to the risk adjustment program; cost-sharing parameters and cost-sharing reductions; and user fees for Federally-facilitated Exchanges and State-based Exchanges on the Federal platform. It also provides additional guidance relating to standardized options; qualified health plans; consumer assistance tools; network adequacy; the Small Business Health Options Program; stand-alone dental plans; fair health insurance premiums; guaranteed renewability; the medical loss ratio program; eligibility and enrollment; appeals; and other related topics

View on regulations.gov →

Co-filers (71)

See everyone who commented →